Article info
PDFPostScript
Letter
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
- Correspondence to Jackie Palace, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK; Jacqueline.palace{at}ndcn.ox.ac.uk
Citation
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
Publication history
- Received August 9, 2013
- Revised November 8, 2013
- Accepted November 11, 2013
- First published November 29, 2013.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions